201 related articles for article (PubMed ID: 2931053)
1. Dermatitis produced by applications of monobenzone in patients with active vitiligo.
Nordlund JJ; Forget B; Kirkwood J; Lerner AB
Arch Dermatol; 1985 Sep; 121(9):1141-4. PubMed ID: 2931053
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model.
Faas L; Venkatasamy R; Hider RC; Young AR; Soumyanath A
Br J Dermatol; 2008 May; 158(5):941-50. PubMed ID: 18284389
[TBL] [Abstract][Full Text] [Related]
3. Irritancy of dithranol in normally pigmented and depigmented skin of patients with vitiligo.
van de Kerkhof PC; Fokkink HJ
Acta Derm Venereol; 1989; 69(3):236-8. PubMed ID: 2566228
[TBL] [Abstract][Full Text] [Related]
4. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic update on vitiligo.
Sarnoff DS
J Drugs Dermatol; 2015 Feb; 14(2):109-11. PubMed ID: 25689803
[No Abstract] [Full Text] [Related]
6. Contact hypersensitivity to monobenzyl ether of hydroquinone used to treat vitiligo.
Lyon CC; Beck MH
Contact Dermatitis; 1998 Sep; 39(3):132-3. PubMed ID: 9771988
[No Abstract] [Full Text] [Related]
7. Depigmentation therapies for normal skin in vitiligo universalis.
AlGhamdi KM; Kumar A
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
[TBL] [Abstract][Full Text] [Related]
8. Facial acne during topical pimecrolimus therapy for vitiligo.
Li JC; Xu AE
Clin Exp Dermatol; 2009 Oct; 34(7):e489-90. PubMed ID: 19747326
[No Abstract] [Full Text] [Related]
9. Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin.
Kasraee B; Fallahi MR; Ardekani GS; Ebrahimi S; Doroudchi G; Omrani GR; Handjani F; Amini M; Tanideh N; Haddadi M; Nikbakhsh M; Jahanbani S; Tran C; Sorg O; Saurat JH
Exp Dermatol; 2006 Jul; 15(7):509-14. PubMed ID: 16761959
[TBL] [Abstract][Full Text] [Related]
10. [Irreversible toxic depigmentation. Observations following use of hydroquinonemonobenzylether-containing skin bleaching preparations].
Heilgemeir GP; Balda BR
MMW Munch Med Wochenschr; 1981 Jan; 123(2):47-8. PubMed ID: 6782448
[No Abstract] [Full Text] [Related]
11. The therapeutic effects of EGCG on vitiligo.
Zhu Y; Wang S; Lin F; Li Q; Xu A
Fitoterapia; 2014 Dec; 99():243-51. PubMed ID: 25128425
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of vitiligo].
Frenk E
Hautarzt; 1986 Jan; 37(1):1-5. PubMed ID: 3949507
[TBL] [Abstract][Full Text] [Related]
13. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir.
Dogra S; Kumar B
Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926
[TBL] [Abstract][Full Text] [Related]
14. Corneal and conjunctival effects of monobenzone in patients with vitiligo.
Hedges TR; Kenyon KR; Hanninen LA; Mosher DB
Arch Ophthalmol; 1983 Jan; 101(1):64-8. PubMed ID: 6849655
[TBL] [Abstract][Full Text] [Related]
15. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
[TBL] [Abstract][Full Text] [Related]
16. Eruptive cherry angiomas associated with vitiligo: provoked by topical nitrogen mustard?
Ma HJ; Zhao G; Shi F; Wang YX
J Dermatol; 2006 Dec; 33(12):877-9. PubMed ID: 17169094
[TBL] [Abstract][Full Text] [Related]
17. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
Hartmann A; Bröcker EB; Hamm H
J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
[TBL] [Abstract][Full Text] [Related]
18. Pimecrolimus cream in repigmentation of vitiligo.
Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
[TBL] [Abstract][Full Text] [Related]
19. Mercury-induced systemic allergic dermatitis caused by 'white precipitate' in a skin lightening cream.
Ozkaya E; Mirzoyeva L; Otkür B
Contact Dermatitis; 2009 Jan; 60(1):61-3. PubMed ID: 19125729
[No Abstract] [Full Text] [Related]
20. A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo.
Agarwal S; Ramam M; Sharma VK; Khandpur S; Pal H; Pandey RM
Br J Dermatol; 2005 Jul; 153(1):163-6. PubMed ID: 16029343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
